Workflow
WELLTRUST™
icon
Search documents
HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold
TMX Newsfile· 2026-03-19 11:00
Core Insights - HEALWELL AI Inc. reported record revenue of approximately $103.8 million for fiscal 2025, marking a 427% increase from $19.7 million in fiscal 2024, and achieved its first full year of positive Adjusted EBITDA of $2.3 million [4][5] Financial Performance - The company experienced a significant financial transformation, swinging from a $14.2 million Adjusted EBITDA loss in 2024 to a $2.3 million positive Adjusted EBITDA in 2025, reflecting a $16.5 million improvement [2][4] - HEALWELL ended 2025 with $18.6 million in cash, compared to $9.4 million at the end of 2024, indicating an improving balance sheet [4][5] - The company reported an IFRS net loss from continuing operations of $39.1 million in 2025, compared to a net loss of $24 million in 2024 [5] Operational Highlights - HEALWELL transitioned to a pure-play AI and software company, completing strategic divestments that generated approximately $9.7 million in cash proceeds [4][5] - The company achieved a gross profit of $57.3 million in 2025, with a gross margin percentage of 55%, consistent with the previous year [5] - In Q4 2025, HEALWELL reported quarterly revenue of $32.2 million, a 374% increase from $6.8 million in Q4 2024, and positive Adjusted EBITDA of $1.1 million [5][9] Strategic Initiatives - HEALWELL has established a competitive position with 47 peer-reviewed publications supporting its DARWEN AI engine and over 70 enterprise customers across 11 countries [2][4] - The company is focusing on global scaling, deepening AI adoption, and translating platform economics into sustained profitability in 2026 [2][4] - HEALWELL launched WELLTRUST™, a consent-first patient identification platform, and announced a multi-million dollar U.S. Health Information Exchange (HIE) contract, expanding its enterprise data interoperability footprint [9]
HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research
TMX Newsfile· 2026-02-19 08:15
Core Insights - HEALWELL AI Inc. and WELL Health Technologies Corp. have launched WELLTRUST™, a platform designed for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada [1][10]. Company Overview - HEALWELL AI focuses on preventative care through healthcare artificial intelligence, aiming to improve healthcare outcomes by early disease detection and clinical decision support systems [7]. - WELL Health Technologies aims to empower healthcare providers through technology, operating over 240 clinics in Canada and serving more than 43,000 healthcare providers across North America [8]. Platform Features - WELLTRUST accelerates clinical research recruitment by allowing patients to consent to future outreach for clinical trials, combining WELL's clinical footprint with HEALWELL's AI capabilities [2][10]. - The platform provides a privacy-preserving infrastructure that enables ethical patient identification and research acceleration while allowing patients to opt-out if they choose [2][11]. - WELLTRUST includes a robust governance and compliance framework to meet Canadian privacy standards, facilitating partnerships with pharmaceutical sponsors and research organizations [11]. Leadership Commentary - Dr. Alexander Dobranowski from HEALWELL emphasized the platform's commitment to responsible AI in healthcare, aiming to enhance patient access to innovations while maintaining privacy [3]. - Dr. Michael Frankel from WELL highlighted the importance of technology in improving healthcare outcomes and empowering patients to participate in research safely [5].